Ensho Therapeutics has presented additional data supporting NSHO-101, also referred to as EA1080, as an oral one-time-a-day ...
Up to 40% of patients with inflammatory bowel disease (IBD) experience extraintestinal manifestations (EIMs), with the ...
A ginger compound, furanodienone (FDN), has been found to reduce inflammation and repair gut damage in IBD patients by ...
Johnson & Johnson, a leader in immunology, has developed ARGES, a new AI-powered tool that could transform endoscopic ...
Celltrion booth at inflammatory bowel disease research gathering Visitors attend a presentation by South Korean ...
Factors linked to C difficile infection in patients with IBD include IBD activity prior to infection, shorter disease ...
Teva and Sanofi's duvakitug showed promising results in a Phase 2b study for ulcerative colitis and Crohn's disease, with ...
It basically kept getting passed off as, like, anxiety or stress since I was meeting someone new and eating new foods...” ...
Major Cause of Inflammatory Bowel Disease Discovered June 5, 2024 — Researchers have discovered a new biological pathway that is a principal driver of inflammatory bowel disease (IBD ...
Switching from IV to subcutaneous infliximab maintenance therapy is associated with high treatment persistence and a stable ...
Tampa Bay Lightning forward Michael Eyssimont was diagnosed with Crohn's disease eight years ago at the age of 21. Since then, he's found a way to manage the disease with treatment and a strict diet.
Inflammatory bowel disease (IBD) affects between 2.4 and 3.1 million people across the United States, according to the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results